Bridge Biotherapeutics (288330), a South Korean biotechnology company, could seek to become the country’s response to the strategy (MSTR) or Metaplanet (3350) by adopting a Bitcoin treasure strategy.
The bridge based in Seongnam received support of 25 billion won (183.3 million dollars) from the investment company of Crypto Parataxis, with which it will build a BTC treasure.
Bridge will change its business name to Korea Parataxy and will continue to negotiate Kosdaq South Korean stock market Kosdaq, according to an announcement on Friday.
“Inspired by the growing interest in BTC treasury strategies observed in companies such as strategy in the United States and Metaplanet in Japan, we believe that institutional interest in this space increases globally,” said Parataxis partner Andrew Kim.
More and more companies copy the Playbook of Strategy, which has more than 2.8% of all the Bitcoin that will ever exist. The operator of the hotel classified in Tokyo who has become the investor Bitcoin Metaplanet holds 10,000 BTC ($ 1.04 billion), making it the greatest holding of a public enterprise outside North America.
These companies have experienced a spectacular assessment in their action course while traders encourage it as a Bitcoin-Proxyctive.
Bridge joins other adjacent health care companies Semler Scientific (SMLR) and Prenetics Global (PRE) in the adoption of a Bitcoin cash strategy.
Parataxis is currently preparing to make public in the United States via an acquisition company for special purposes (SPAC), Silverbox Corp IV (SBXD).
Pont shares closed more than 20.5% more Friday at 943 won ($ 0.69).
